You must be 21 years old to enter this site
Please state that you are 21 or older

While our specific product offerings will ultimately rely on the availability of products within the wholesale market, we will work closely with our grower and processor partners to develop products that will best meet the needs of our patients.

We will seek to offer to our patients products based on the following medical cannabis strains (or those reliable alternatives with similar cannabinoid profiles) as our initial targets.

These strains provide a varied mix of cannabinoid contents as well as species (indica, sativa, indica dominant hybrids, sativa dominant hybrids, and 50/50 hybrids). Specifically, Cannatonic, MJardin CBD, and Harlequin are higher in cannabidiol (CBD) content than most cannabis strains. Cannabidiol (CBD) is a promising nonpsychoactive constituent widely accepted in medical and non-medical communities for minimizing chronic pain, seizures, and epilepsy. CBD blocks and stabilizes excitatory receptors such as NMDA, the over-reactive receptors in most epileptic conditions. A potent anti-inflammatory, anti-spasmodic, and neuro-protective substance, CBD dramatically reduces anxiety without affecting mental processes. CBD is well known for providing relaxation without sedation and relief without intoxication. We will offer products based on the following high-CBD strains:

While we plan to offer a wide variety of strains with varying THC and CBD levels we cannot guarantee which strains these will be as we are dependent upon what strains are offered by Maryland Growers.

In addition to our cannabis flower product offerings, we will offer our patients medical cannabis extracts, both in liquid (oil) and solid (crystalline, wax) forms, ideally processed using carbon dioxide extraction processes. The solvent capacity of carbon dioxide can be tuned to selectively extract specific cannabinoid contents over others, providing another mechanism for tuning the composition of the final medical product. The resulting cannabis extracts range from 30-75% cannabinoids by weight. This concentration can be increased by simple physical and mechanical purification methods. Utilizing a food-grade solvent , e.g. organic cane-sugar-derived 200 proof alcohol, in conjunction with carbon dioxide solvent-tuning methods can yield extract products reaching as high as 90% cannabinoids by weight.

The extracts generated from both THC-dominant and CBD-dominant strains of medical cannabis have been used in studies (http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php) demonstrating their impact on and treatment of pain and inflammation reduction, multiple sclerosis, seizures, cancer, epilepsy, HIV, nausea, and glaucoma, among others.

We will continue to monitor research associated with chemical compositions and their effects on medical conditions to best identify products that address our patients’ medical conditions.

In addition, you may get a recommendation if you have a chronic or debilitating disease or medical condition that causes: Severe loss of appetite, Cachexia (Wasting Syndrome), Severe, debilitating or chronic pain, Severe nausea, Seizures, Severe and persistent muscle spasms, Glaucoma, Epilepsy, Post Traumatic Stress Disorder.
If you have a condition that is not listed your doctor may request the MMCC to approve on a case by base basis.